Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-09
J
Justin M. Pressley
Role not yet determined Is this you? Add your title
Also affiliated: University of South Carolina (2023); Baylor University (2023)
2 h-index
5 pubs
13 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Justin Pressley's research program investigates the pharmacological effects of novel opioid compounds, with a focus on fentanyl analogs. His work examines their impact on antinociception, the development of dependence and withdrawal symptoms, and the behavioral defense of drug consumption in animal models. Pressley also studies the influence of environmental factors, such as diesel exhaust particles, on the blood-brain barrier's P-glycoprotein efflux transporter in the context of neuroinflammation. He has also contributed to research on the development of polo-like kinase 1 (PLK1) inhibitors as potential therapeutics for various cancers. Pressley's scholarly output includes four publications with 11 citations, and he holds an h-index of 2. He has collaborated with researchers Brenda M. Gannon, William E. Fantegrossi, Jeffery H. Moran, and Mary E Shepard at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 2
- Publications: 5
- Citations: 13
Selected Publications
-
Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452) (2026)
-
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
Collaboration Network
Top Collaborators
Marina Avram
nPoint (United States)
2 shared publications
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
Jeffery H. Moran
nPoint (United States)
2 shared publications
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
Brenda M. Gannon
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Mary E Shepard
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Hannah E. Shaw
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
William E. Fantegrossi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
John Westphal
Hope College (US)
1 shared publication
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
John T. Striednig
University of Arkansas for Medical Sciences
1 shared publication
In database
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
Brenda M. Gannon
University of Arkansas for Medical Sciences
1 shared publication
In database
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
Isabel L. Ritter
nPoint (United States) (US)
1 shared publication
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
William Fantegrossi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452)
Similar Researchers
Based on overlapping research topics
Charles E. Hay
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies
John T. Striednig
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies
Justin R. Nickell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies
C. Keisling
Harding University Main Campus
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Michael D. Berquist
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies
Brenda M. Gannon
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies